Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Gates Foundation

Global: To Develop a Highly Sensitive Urine-based Test for TB, Which Has Improved Performance and May Be Used to Detect TB Patients with or Without HIV

Last update: Mar 13, 2026 Last update: Mar 13, 2026

Details

Locations:USA
Start Date:Jan, 2020
End Date:Jun, 2023
Contract value: USD 1,324,244
Sectors:Health, Research & Innovation
 Health, Research & Innovation
Categories:Grants
Funding Agencies:
Gates Foundation
Date posted:Mar 13, 2026
Contracting authority:Gates Foundation

Associated funding

Associated experts

Description

Purpose: To develop a highly sensitive urine-based test for TB, which has improved performance and may be used to detect TB in patients with or without HIV
Division: Global Health
Region served: GLOBAL
Grant topic: Tuberculosis
Duration (months): 41
Grantee location: Newark, New Jersey, United States

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.
Learn more about our membership benefits
Print